CREAPHARM is a French company managing clinical supplies and providing CMO and distribution services for pharmaceuticals and cosmetics. Its CEO, Eric Placet, explains how he has reorganized the company to create synergies between the different business lines and breaks down the massive investments the company has made over the last three years to reach its ambitious growth target. Among other things, he also discusses how the company has prepared to survive the European serialization law, the regulatory trends in France, and his strategy for the US market and globally.
The key success factor to answer [biotech companies'] needs is reactivity and, as a mid-size business, we have the flexibility to work with them efficiently
